Title:
SWEETNESS RECEPTOR ANTAGONIST
Document Type and Number:
WIPO Patent Application WO/2019/078116
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a sweetness receptor antagonist that is useful in the prevention or treatment of, for example, metabolic syndrome, diabetes or obesity. A sweetness receptor antagonist comprising a compound represented by formula (I), or a salt thereof. (In the formula, each symbol is as disclosed in the specification.)
Inventors:
KITAHARA YOSHIRO (JP)
OHSUMI KOJI (JP)
KITAJIMA SEIJI (JP)
OGAWA SHINPEI (JP)
OHSUMI KOJI (JP)
KITAJIMA SEIJI (JP)
OGAWA SHINPEI (JP)
Application Number:
PCT/JP2018/038130
Publication Date:
April 25, 2019
Filing Date:
October 12, 2018
Export Citation:
Assignee:
AJINOMOTO KK (JP)
International Classes:
A61K31/155; A61P3/00; A61P3/04; A61P3/10; A61P5/50; A61P43/00
Foreign References:
| JP2004527546A | 2004-09-09 | |||
| JP2007501861A | 2007-02-01 | |||
| JP2010531437A | 2010-09-24 | |||
| JPH03500295A | 1991-01-24 |
Other References:
SCHILLING, A. ET AL.: "Behavioral study in the Gray Mouse Lemur(Microcebus murinus) using compounds considered sweet by humans", AMERICAN JOURNAL OF PRIMATOLOGY, vol. 62, 2004, pages 43 - 48, XP055596853
Attorney, Agent or Firm:
TAKASHIMA, Hajime et al. (JP)
Download PDF: